Osteoporosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a white/Caucasian woman between 35 and 70 years old
- You have been diagnosed with breast cancer and are being treated with certain hormone-blocking medications (aromatase inhibitors, or tamoxifen combined with hormone-suppressing injections, or both) that were started no more than 12 months ago, and you are about to begin taking a bone-strengthening tablet called alendronate
- Your vitamin D levels were found to be low (below 30 ng/ml) in a blood test done within the last 6 months
- You are able and willing to follow all the requirements and procedures of the study
- You are willing to sign a consent form agreeing to take part and to have your data used, either personally or with the help of a witness, before any study procedures begin
Who may not be able to join:
- You have poorly controlled diabetes or severely reduced kidney function (confirm with trial site)
- You have a condition where your parathyroid glands are overactive, whether caused by kidney disease or another reason
- Your vitamin D levels are already at 30 ng/ml or above
- You are already taking bone-protecting medications (anti-resorptive drugs)
- You are currently taking steroid medications
- You are already taking other forms of vitamin D (such as calcifediol or calcitriol) or need to take high doses of calcium due to underactive parathyroid glands
- You are taking water tablets (diuretics) or other medications that affect how your body handles calcium
- You are unable or unwilling to follow the procedures required by the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marialuisa Appetecchia, MD, Regina Elena National Cancer Insitute
Phone: 0039 0652666026
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of differences in mean vitamin D levels after six months in patients treated with calcium carbonate + cholecalciferoland patients treated with calcium carbonate + cholecalciferol + vitamin K + α-lactalbumin + d-chiro-inositol
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.